CompletedEUCTR 2005-005812-25

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexi...

This historical record does not confirm current site availability.

Historical research recordGreece + LithuaniaBipolarity

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Greece · Lithuania
Study phase: Phase 3

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 475
Sponsor: Janssen-Cilag International N.V.
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: Greece, Lithuania
Age range: Not clearly listed
Official registry ID: EUCTR 2005-005812-25
Official title: Show the full official title
A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexi...

Looking for a study you can join?

Explore recruiting studies

Get this study by email

Recruitment & locations

Completed

Greece · Lithuania

Registry details

Historical country statuses

Greece — Completed
Lithuania — Completed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag International N.V.

Want to explore more studies?

Explore studies